1991 - 2000 of 6078 Results
Title
Year
- Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial2022OPENTitle: Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trialJournal Name: The Lancet MicrobePublisher: Elsevier BVVol: 3Issue #: 3Start Page: e203End Page: e214Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2666-5247(21)00239-1Best OA location URL: http://www.thelancet.com/article/S2666524721002391/pdfCitation Count: 56
- Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patients2022OPENTitle: Lamina-specific immunohistochemical signatures in the olfactory bulb of healthy, Alzheimer’s and Parkinson’s disease patientsJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03032-5Best OA location URL: https://www.nature.com/articles/s42003-022-03032-5.pdfCitation Count: 26
- Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's disease2022OPENTitle: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 38End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017Best OA location URL: http://www.prd-journal.com/article/S1353802022000256/pdfCitation Count: 23
- No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological Significance2022OPENTitle: No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological SignificanceJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 653End Page: 653Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28935Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940713Citation Count: 5
-
OPENTitle: Head tremor in cervical dystonia: Quantifying severity with computer visionJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 434Issue #:Start Page: 120154End Page: 120154Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jns.2022.120154Best OA location URL: http://manuscript.elsevier.com/S0022510X22000132/pdf/S0022510X22000132.pdfCitation Count: 11
- Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-up2022OPENTitle: Stimulation of the pedunculopontine and cuneiform nuclei for freezing of gait and falls in Parkinson disease: Cross-over single-blinded study and long-term follow-upJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.010Best OA location URL: http://manuscript.elsevier.com/S1353802022000189/pdf/S1353802022000189.pdfCitation Count: 13
-
OPENTitle: Disease-Modifying Antirheumatic Drugs and Risk of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000013303Best OA location URL: https://n.neurology.org/content/neurology/98/12/e1273.full.pdfCitation Count: 19
-
OPENTitle: Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9Journal Name: NeuronPublisher: Elsevier BVVol: 110Issue #: 5Start Page: 824End Page: 840.e10Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuron.2021.12.031Best OA location URL: http://www.cell.com/article/S089662732101076X/pdfCitation Count: 73
-
OPENTitle: Quantifying regional α ‐synuclein, amyloid β, and tau accumulation in lewy body dementiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 9Issue #: 2Start Page: 106End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51482Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51482Citation Count: 31
- Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease2022OPENTitle: Differential Phospho‐Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1004End Page: 1015Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28927Best OA location URL: https://diposit.ub.edu/dspace/bitstream/2445/183417/1/718962.pdfCitation Count: 13